These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17394608)

  • 1. Anidulafungin--state of affairs from a clinical perspective.
    Vehreschild JJ; Kümmerle T; Karthaus M; Cornely OA
    Mycoses; 2007; 50 Suppl 1():38-43. PubMed ID: 17394608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echinocandins: the newest class of antifungals.
    Sucher AJ; Chahine EB; Balcer HE
    Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology and antifungal properties of anidulafungin, a new echinocandin.
    Estes KE; Penzak SR; Calis KA; Walsh TJ
    Pharmacotherapy; 2009 Jan; 29(1):17-30. PubMed ID: 19113794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anidulafungin: a novel echinocandin for candida infections.
    de la Torre P; Meyer DK; Reboli AC
    Future Microbiol; 2008 Dec; 3(6):593-601. PubMed ID: 19072176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echinocandin antifungal drugs in fungal infections: a comparison.
    Chen SC; Slavin MA; Sorrell TC
    Drugs; 2011 Jan; 71(1):11-41. PubMed ID: 21175238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anidulafungin: when and how? The clinician's view.
    George J; Reboli AC
    Mycoses; 2012 Jan; 55(1):36-44. PubMed ID: 21668526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The echinocandins: three useful choices or three too many?
    Bal AM
    Int J Antimicrob Agents; 2010 Jan; 35(1):13-8. PubMed ID: 19942413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anidulafungin: advantage for the newcomer?
    Rüping MJ; Vehreschild JJ; Farowski F; Cornely OA
    Expert Rev Clin Pharmacol; 2008 Mar; 1(2):207-16. PubMed ID: 24422646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of invasive candidiasis with echinocandins.
    Glöckner A; Steinbach A; Vehreschild JJ; Cornely OA
    Mycoses; 2009 Nov; 52(6):476-86. PubMed ID: 19076282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anidulafungin: a new echinocandin with a novel profile.
    Vazquez JA
    Clin Ther; 2005 Jun; 27(6):657-73. PubMed ID: 16117974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echinocandin pharmacodynamics: review and clinical implications.
    Pound MW; Townsend ML; Drew RH
    J Antimicrob Chemother; 2010 Jun; 65(6):1108-18. PubMed ID: 20335190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections.
    Kuti EL; Kuti JL
    Expert Opin Drug Metab Toxicol; 2010 Oct; 6(10):1287-300. PubMed ID: 20822479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of anidulafungin therapy in solid organ transplant recipients].
    Fortún Abete J; Martín-Dávila P
    Rev Iberoam Micol; 2008 Jun; 25(2):129-33. PubMed ID: 18473508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anidulafungin: is it a promising option in the treatment of pediatric invasive fungal infections?
    Tapısız A
    Expert Rev Anti Infect Ther; 2011 Mar; 9(3):339-46. PubMed ID: 21417873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anidulafungin in the treatment of patients with invasive candidiasis.
    Kett DH; Cubillos GF
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S99-S102. PubMed ID: 19013348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive fungal infections: the challenge continues.
    Gullo A
    Drugs; 2009; 69 Suppl 1():65-73. PubMed ID: 19877737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Echinocandins in invasive candidiasis].
    Glöckner A; Cornely OA
    Med Klin (Munich); 2008 Jun; 103(6):397-405. PubMed ID: 18548209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Potential of anidulafungin in hematological patients].
    Vázquez López L; Ruiz Camps I
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():44-50. PubMed ID: 19572434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anidulafungin: a new echinocandin for candidal infections.
    de la Torre P; Reboli AC
    Expert Rev Anti Infect Ther; 2007 Feb; 5(1):45-52. PubMed ID: 17266452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anidulafungin, a new echinocandin: effectiveness and tolerability.
    Menichetti F
    Drugs; 2009; 69 Suppl 1():95-7. PubMed ID: 19877741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.